2026年11月2日,Barclays PLC以每股均价3.1414港元减持健康160(02656)股份2573.82万股,持股量降至5%以下;该笔交易在联交所场内通过公开市场撮合成交,属二级市场直接买卖,涉资约8085.41万港元。
Barclays PLC此次减持前持有健康160好仓3401.38万,占比9.8%;减持后持股量为827.55万,好仓比例降至2.38%。
2026年11月2日,Barclays PLC以每股均价3.1414港元减持健康160(02656)股份2573.82万股,持股量降至5%以下;该笔交易在联交所场内通过公开市场撮合成交,属二级市场直接买卖,涉资约8085.41万港元。
Barclays PLC此次减持前持有健康160好仓3401.38万,占比9.8%;减持后持股量为827.55万,好仓比例降至2.38%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.